Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00341562
Other study ID # 999905234
Secondary ID 05-H-N234
Status Completed
Phase N/A
First received June 19, 2006
Last updated March 3, 2008
Start date September 2005
Est. completion date July 2006

Study information

Verified date July 2006
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Observational

Clinical Trial Summary

This study, conducted in Argentina at the Hospital Espa ol de la Plata and the Hospital Franc s de Buenos Aires, in collaboration with the NHLBI, will investigate possible genetic factors that lead to in-stent restenosis. A stent is a wire mesh tube that is surgically placed to open a blocked artery. The stent stays in the artery permanently, holding it open to improve blood flow. In the case of blocked coronary arteries, the stent improves blood flow to the heart muscle, relieving symptoms such as chest pain and shortness of breath. Sometimes re-growth of tissue within a stent, called in-stent restenosis, leads to narrowing of the artery, decreased blood flow, and a recurrence of symptoms. Genetic analysis may allow the identification of patient that may be at increased risk for in-stent restenosis and lead to methods of prevention and treatment.

Patients 18 years of age and older who are undergoing coronary endarterectomy (surgery to remove plaque from an artery) to treat in-stent restenosis at the Hospital Espa ol de la Plata and the Hospital Franc s de Buenos Aires may be eligible for this study.

Participants will have a blood sample drawn and undergo coronary endarterectomy. Tissue removed from the patient's artery or the stent during surgery will be analyzed for gene expression profiling and genotyping. The results will be studied along with information about the patients' medical history.


Description:

Our laboratory is investigating the genetic basis of the vascular disease, in-stent restenosis. We hypothesize that patients with in-stent restenosis have abnormal expression of cell cycle regulatory and inflammatory genes that lead to accelerated development of vascular lesions following angioplasty, and that there is a genetic component underlying individual differences to vascular injury. We are conducting an investigation of human subjects with in-stent restenosis, entitled the CardioGene Study. The objective of the CardioGene study is to identify the genetic profile of patients at risk for in-stent restenosis. The CardioGene study completed enrollment of 465 patients in December 2004. Analysis of blood gene expression profiles, proteomic and genotyping data is currently ongoing. All analyses are conducted using peripheral blood. Concurrent analysis of restenosis tissue samples would be valuable in defining the molecular genetics of the disease.

In this complementary study of endartectomy tissues, we will collect diseased restenosis tissues removed from patients as part of their routine clinical care. We will also collect blood at the time of tissue harvesting for genomic analysis, in addition to clinical data. Genomic data will be compared to the CardioGene study findings, for the purposes of validation as well as more detailed understanding of the biology of restenosis, by investigation the molecular mechanisms of restenosis in the tissue samples.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date July 2006
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility - INCLUSION CRITERIA

Patients 18 years of age or older

Patients undergoing coronary endarterectomy as part of their course of medical therapy. The lesion for which endarterectomy is being performed is restenosis within a bare metal stent within a native coronary artery

EXCLUSION CRITERIA

Current enrollment in a clinical trial for the treatment or prevention of in-stent restenosis.

Lesion within saphenous vein graft following coronary artery bypass grafting

Patients younger than 18 years of age

The patient is unable to provide informed consent

Study Design

N/A


Related Conditions & MeSH terms


Locations

Country Name City State
United States National Heart, Lung and Blood Institute (NHLBI) Bethesda Maryland

Sponsors (1)

Lead Sponsor Collaborator
National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Hayashi S, Watanabe N, Nakazawa K, Suzuki J, Tsushima K, Tamatani T, Sakamoto S, Isobe M. Roles of P-selectin in inflammation, neointimal formation, and vascular remodeling in balloon-injured rat carotid arteries. Circulation. 2000 Oct 3;102(14):1710-7. — View Citation

See also
  Status Clinical Trial Phase
Completed NCT01205776 - EXCEL Clinical Trial N/A
Completed NCT02542267 - In-Stent Restenosis Post-Approval Study N/A
Completed NCT01608035 - Sciatic Perineural Versus Stump Catheter for Below Knee Amputation Phase 0
Completed NCT00987181 - Non-Contact Measurement of Aortic Compliance N/A
Completed NCT00759681 - ArterX Surgical Sealant, A Randomized Prospective Multicenter Trial Phase 3
Completed NCT00865124 - Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease N/A
Completed NCT01182428 - XIENCE V: SPIRIT WOMEN Sub-study Phase 4
Completed NCT00633659 - Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia Phase 2
Completed NCT00110604 - The Effect of Folic Acid on Atherosclerosis, Cognitive Performance and Hearing N/A
Completed NCT01355406 - Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System N/A
Not yet recruiting NCT02843854 - Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms Phase 1
Completed NCT01221610 - BIOLUX P-I First in Man Study N/A
Completed NCT01205789 - EXCEL Clinical Trial (Universal Registry) N/A
Completed NCT01229358 - Clinical Trial of a Silver Eluting Dressing System Phase 4
Recruiting NCT01358630 - Vascular and Periodontal Disease - Microbial, Genetic and Histological Causalities N/A
Completed NCT00782015 - Effects of Almonds on Vascular Reactivity in Patients With Coronary Artery Disease N/A
Completed NCT00805831 - Safety and Efficacy of Using HDH Device and Method - a Novel Sutureless Vascular Anastomosis N/A
Withdrawn NCT00334724 - Home Blood Pressure-guided Antihypertensive Intervention for Elderly (HBP-GUIDE) Study Phase 4
Active, not recruiting NCT02751099 - Bone and Cardiovascular Disease After Kidney Transplant
Completed NCT02562781 - Is Peri-operative Hyperoxemia a Risk Factor for Postoperative Complications? Phase 3